Clinical characteristics in HM1 family
ID | Sex | Age (years) | Status | Refraction (D) | Axial length (mm) | Fundus | Genotype | ||
Ocular Dexter (OD) | Oculus Sinister (OS) | OD | OS | ||||||
I:2 | F | 80–85 | Patient | −14.00 | −14.00 | 29.12 | 28.09 | Retinal atrophy | c.539C>T, Het |
II:2 | F | 60–65 | Patient | −15.00 | −10.00 | 29.34 | 27.61 | Bilateral tigroid fundus | c.539C>T, Het |
II:4 | F | 55–60 | Patient | −15.00 | −15.00 | 29.94 | 29.73 | Bilateral tigroid fundus, retinal atrophy | c.539C>T, Het |
II:6 | F | 55–60 | Normal | Plano | Plano | NA | NA | NA | WT |
III:2 | F | 35–40 | Normal | −2.50 | −2.50 | NA | NA | NA | WT |
III:5 | F | 30–35 | Patient | −12.00* | −12.00 | 27.38 | 28.08 | Bilateral tigroid fundus | c.539C>T, Het |
III:7 | F | 35–40 | Patient | −6.00* | −6.00 | NA | NA | NA | c.539C>T, Het |
III:8 | M | 35–40 | Normal | −1.00 | −1.00 | NA | NA | NA | WT |
III:9 | F | 30–35 | Normal | −0.50 | 0.00 | 23.59 | 23.46 | Normal | c.539C>T, Het |
III:10 | F | 30–35 | Patient | −5.75 | −5.50 | 24.75 | 24.77 | NA | c.539C>T, Het |
III:11 | M | 25–30 | Patient | −8.00 | −8.00 | 26.46 | 26.19 | Normal | c.539C>T, Hemi |
III:12 | F | 25–30 | Normal | −2.00 | −2.00 | NA | NA | NA | WT |
III:13 | M | 15–20 | Normal | Plano | Plano | NA | NA | NA | WT |
III:14 | M | 10–15 | Normal | −1.50 | +2.00 | 26.02 | 24.16 | Normal | WT |
III:15 | F | 15–20 | Normal | Plano | Plano | NA | NA | NA | WT |
IV:2 | M | 5–10 | Normal | Plano | Plano | NA | NA | NA | WT |
IV:3 | F | 5–10 | Normal | Plano | Plano | NA | NA | NA | WT |
IV:4 | M | 5–10 | Patient | −9.00 | −9.00 | 27.48 | 27.26 | Bilateral tigroid fundus, retinal atrophy | c.539C>T, Hemi |
*LASIK eye surgery 10 years before.
F, female; Hemi, hemizygote; Het, heterozygote; M, male; NA, not applicable; WT, wild-type.